VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q40109353  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000319.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q40109353‏
024 ‎‡a  0000-0002-2918-7361‏ ‎‡2  orcid‏
024 ‎‡a  7203072531‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q40109353‏
100 0 ‎‡a  Jaap A. Bakker‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Jaap A. Bakker‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
400 0 ‎‡a  Jaap A. Bakker‏ ‎‡c  investigador‏ ‎‡9  es‏
670 ‎‡a  Author's A comparative study of inosine triphosphatase activity in fresh erythrocytes and dried blood spots‏
670 ‎‡a  Author's A novel multiparameter flow cytometric assay for inosine triphosphatase expression analysis in leukocytes‏
670 ‎‡a  Author's A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis‏
670 ‎‡a  Author's A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?‏
670 ‎‡a  Author's Abnormalities suggestive of latent tuberculosis infection on chest radiography; how specific are they?‏
670 ‎‡a  Author's Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry‏
670 ‎‡a  Author's Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the same fingerstick sample‏
670 ‎‡a  Author's Adducted thumbs: a clinical clue to genetic diagnosis.‏
670 ‎‡a  Author's Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy‏
670 ‎‡a  Author's An HPLC-based assay of adenylosuccinate lyase in erythrocytes‏
670 ‎‡a  Author's Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B‏
670 ‎‡a  Author's Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency?‏
670 ‎‡a  Author's Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors‏
670 ‎‡a  Author's Azathioprine induced pneumonitis in a patient with ulcerative colitis‏
670 ‎‡a  Author's Beneficial Effects of Early Enteral Nutrition After Major Rectal Surgery: A Possible Role for Conditionally Essential Amino Acids? Results of a Randomized Clinical Trial.‏
670 ‎‡a  Author's Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.‏
670 ‎‡a  Author's Biomarkers to identify <i>Mycobacterium tuberculosis</i> infection among borderline QuantiFERON results‏
670 ‎‡a  Author's C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus‏
670 ‎‡a  Author's Carbohydrate co-ingestion with protein does not further augment post-prandial muscle protein accretion in older men‏
670 ‎‡a  Author's Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder‏
670 ‎‡a  Author's Congenital hydrocephalus in clinical practice: a genetic diagnostic approach.‏
670 ‎‡a  Author's Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.‏
670 ‎‡a  Author's Determination of ITPase activity in erythrocyte lysates obtained for determination of TPMT activity‏
670 ‎‡a  Author's Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography‏
670 ‎‡a  Author's Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites‏
670 ‎‡a  Author's Early-pregnancy asymmetric dimethylarginine (ADMA) levels in women prone to develop recurrent hypertension‏
670 ‎‡a  Author's Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production.‏
670 ‎‡a  Author's Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.‏
670 ‎‡a  Author's Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals‏
670 ‎‡a  Author's Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.‏
670 ‎‡a  Author's Gonadal function in male and female patients with classic galactosemia.‏
670 ‎‡a  Author's Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype‏
670 ‎‡a  Author's Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy.‏
670 ‎‡a  Author's Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus‏
670 ‎‡a  Author's Is brain natriuretic peptide production decreased in obese subjects?‏
670 ‎‡a  Author's Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomalies‏
670 ‎‡a  Author's LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease‏
670 ‎‡a  Author's Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity‏
670 ‎‡a  Author's Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder‏
670 ‎‡a  Author's Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice‏
670 ‎‡a  Author's New mutations in two Dutch patients with early infantile galactosialidosis‏
670 ‎‡a  Author's Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy‏
670 ‎‡a  Author's Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome.‏
670 ‎‡a  Author's Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology?‏
670 ‎‡a  Author's Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone‏
670 ‎‡a  Author's PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome‏
670 ‎‡a  Author's Proof of concept that most borderline Quantiferon results are true antigen-specific responses.‏
670 ‎‡a  Author's Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency‏
670 ‎‡a  Author's Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood‏
670 ‎‡a  Author's Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects‏
670 ‎‡a  Author's Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome‏
670 ‎‡a  Author's Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome‏
670 ‎‡a  Author's Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates‏
670 ‎‡a  Author's The diagnostic value of serum and urinary NT-proBNP for heart failure.‏
670 ‎‡a  Author's The effect of ITPA polymorphisms on the enzyme kinetic properties of human erythrocyte inosine triphosphatase toward its substrates ITP and 6-Thio-ITP‏
670 ‎‡a  Author's The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injury‏
670 ‎‡a  Author's The muscle protein synthetic response to the combined ingestion of protein and carbohydrate is not impaired in healthy older men.‏
670 ‎‡a  Author's The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.‏
670 ‎‡a  Author's The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients‏
670 ‎‡a  Author's The T1405N carbamoyl phosphate synthetase polymorphism does not affect plasma arginine concentrations in preterm infants‏
670 ‎‡a  Author's Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.‏
670 ‎‡a  Author's Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?‏
670 ‎‡a  Author's Unexplained familial benign methylmalonic aciduria‏
670 ‎‡a  Author's Untreated classical galactosemia patient with mild phenotype‏
909 ‎‡a  (orcid) 0000000229187361‏ ‎‡9  1‏
909 ‎‡a  (scopus) 7203072531‏ ‎‡9  1‏
919 ‎‡a  proofofconceptthatmostborderlinequantiferonresultsaretrueantigenspecificresponses‏ ‎‡A  Proof of concept that most borderline Quantiferon results are true antigen-specific responses.‏ ‎‡9  1‏
919 ‎‡a  beneficialeffectsofearlyenteralnutritionaftermajorrectalsurgeryapossibleroleforconditionallyessentialaminoacidsresultsofarandomizedclinicaltrial‏ ‎‡A  Beneficial Effects of Early Enteral Nutrition After Major Rectal Surgery: A Possible Role for Conditionally Essential Amino Acids? Results of a Randomized Clinical Trial.‏ ‎‡9  1‏
919 ‎‡a  reducedrenalplasmaclearancedoesnotexplainincreasedplasmaasymmetricdimethylarginineinhypertensivesubjectswithmildtomoderaterenalinsufficiency‏ ‎‡A  Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency‏ ‎‡9  1‏
919 ‎‡a  referencevaluesfornterminalprobtypenatriureticpeptideinumbilicalcordblood‏ ‎‡A  Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood‏ ‎‡9  1‏
919 ‎‡a  renalclearanceofbtypenatriureticpeptideandaminoterminalprobtypenatriureticpeptideamechanisticstudyinhypertensivesubjects‏ ‎‡A  Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects‏ ‎‡9  1‏
919 ‎‡a  serologicalandgeneticcomplementalterationsininfectioninducedandcomplementmediatedhemolyticuremicsyndrome‏ ‎‡A  Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome‏ ‎‡9  1‏
919 ‎‡a  serotonergicnoradrenergicanddopaminergicmarkersarerelatedtocognitivefunctioninadultswith22q11deletionsyndrome‏ ‎‡A  Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome‏ ‎‡9  1‏
919 ‎‡a  tetrahydrobiopterinresponsivephenylalaninehydroxylasedeficiencyindutchneonates‏ ‎‡A  Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Dutch neonates‏ ‎‡9  1‏
919 ‎‡a  diagnosticvalueofserumandurinaryntprobnpforheartfailure‏ ‎‡A  The diagnostic value of serum and urinary NT-proBNP for heart failure.‏ ‎‡9  1‏
919 ‎‡a  effectofitpapolymorphismsontheenzymekineticpropertiesofhumanerythrocyteinosinetriphosphatasetowarditssubstratesitpand6thioitp‏ ‎‡A  The effect of ITPA polymorphisms on the enzyme kinetic properties of human erythrocyte inosine triphosphatase toward its substrates ITP and 6-Thio-ITP‏ ‎‡9  1‏
919 ‎‡a  hypoxanthinexanthineoxidaseaxisisnotinvolvedintheinitialphaseofclinicaltransplantationrelatedischemiareperfusioninjury‏ ‎‡A  The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injury‏ ‎‡9  1‏
919 ‎‡a  muscleproteinsyntheticresponsetothecombinedingestionofproteinandcarbohydrateisnotimpairedinhealthyoldermen‏ ‎‡A  The muscle protein synthetic response to the combined ingestion of protein and carbohydrate is not impaired in healthy older men.‏ ‎‡9  1‏
919 ‎‡a  neteffectofcombiningrituximabwithbelimumabinseveresystemiclupuserythematosus‏ ‎‡A  The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.‏ ‎‡9  1‏
919 ‎‡a  pharmacokineticeffectofadalimumabonthiopurinemetabolismincrohnsdiseasepatients‏ ‎‡A  The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients‏ ‎‡9  1‏
919 ‎‡a  t1405ncarbamoylphosphatesynthetasepolymorphismdoesnotaffectplasmaarginineconcentrationsinpreterminfants‏ ‎‡A  The T1405N carbamoyl phosphate synthetase polymorphism does not affect plasma arginine concentrations in preterm infants‏ ‎‡9  1‏
919 ‎‡a  therapeuticdrugmonitoringofthiopurinemetabolitesinadultthiopurinetolerantibdpatientsonmaintenancetherapy‏ ‎‡A  Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.‏ ‎‡9  1‏
919 ‎‡a  therapeuticregimensininterstitiallungdiseaseguidedbygeneticscreeningfactorfiction‏ ‎‡A  Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?‏ ‎‡9  1‏
919 ‎‡a  unexplainedfamilialbenignmethylmalonicaciduria‏ ‎‡A  Unexplained familial benign methylmalonic aciduria‏ ‎‡9  1‏
919 ‎‡a  untreatedclassicalgalactosemiapatientwithmildphenotype‏ ‎‡A  Untreated classical galactosemia patient with mild phenotype‏ ‎‡9  1‏
919 ‎‡a  c1qdeficiencyandneuropsychiatricsystemiclupuserythematosus‏ ‎‡A  C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus‏ ‎‡9  1‏
919 ‎‡a  arechildrenwithcysticfibrosiswhoaretreatedwithaprotonpumpinhibitoratriskforvitaminb12deficiency‏ ‎‡A  Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency?‏ ‎‡9  1‏
919 ‎‡a  biomarkerstoidentify1mycobacteriumtuberculosis1infectionamongborderlinequantiferonresults‏ ‎‡A  Biomarkers to identify <i>Mycobacterium tuberculosis</i> infection among borderline QuantiFERON results‏ ‎‡9  1‏
919 ‎‡a  carbohydratecoingestionwithproteindoesnotfurtheraugmentpostprandialmuscleproteinaccretioninoldermen‏ ‎‡A  Carbohydrate co-ingestion with protein does not further augment post-prandial muscle protein accretion in older men‏ ‎‡9  1‏
919 ‎‡a  clinicalandbiochemicalpresentationofsiblingswithcog7deficiencyalethalmultipleoandnglycosylationdisorder‏ ‎‡A  Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder‏ ‎‡9  1‏
919 ‎‡a  arechildrenwithcysticfibrosiswhoaretreatedwithaprotonpumpinhibitoratriskforvitaminb‏ ‎‡A  Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B‏ ‎‡9  1‏
919 ‎‡a  hplcbasedassayofadenylosuccinatelyaseinerythrocytes‏ ‎‡A  An HPLC-based assay of adenylosuccinate lyase in erythrocytes‏ ‎‡9  1‏
919 ‎‡a  congenitalhydrocephalusinclinicalpracticeageneticdiagnosticapproach‏ ‎‡A  Congenital hydrocephalus in clinical practice: a genetic diagnostic approach.‏ ‎‡9  1‏
919 ‎‡a  defectivepostreperfusionmetabolicrecoverydirectlyassociateswithincidentdelayedgraftfunction‏ ‎‡A  Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.‏ ‎‡9  1‏
919 ‎‡a  determinationofitpaseactivityinerythrocytelysatesobtainedfordeterminationoftpmtactivity‏ ‎‡A  Determination of ITPase activity in erythrocyte lysates obtained for determination of TPMT activity‏ ‎‡9  1‏
919 ‎‡a  directnonradioactiveassayofgalactose1phosphateuridyltransferaseactivityusinghighperformanceliquidchromatography‏ ‎‡A  Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography‏ ‎‡9  1‏
919 ‎‡a  earlyinfantiletypeofgalactosialidosisasacauseofheartfailureandneonatalascites‏ ‎‡A  Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites‏ ‎‡9  1‏
919 ‎‡a  earlypregnancyasymmetricdimethylarginineadmalevelsinwomenpronetodeveloprecurrenthypertension‏ ‎‡A  Early-pregnancy asymmetric dimethylarginine (ADMA) levels in women prone to develop recurrent hypertension‏ ‎‡9  1‏
919 ‎‡a  elevatedcitratelevelsinnonalcoholicfattyliverdiseasethepotentialofcitratetopromoteradicalproduction‏ ‎‡A  Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production.‏ ‎‡9  1‏
919 ‎‡a  erythrocyteinosinetriphosphataseactivityapotentialbiomarkerforadverseeventsduringcombinationantiretroviraltherapyforhiv‏ ‎‡A  Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.‏ ‎‡9  1‏
919 ‎‡a  erythrocyteinosinetriphosphataseactivityisdecreasedinhivseropositiveindividuals‏ ‎‡A  Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals‏ ‎‡9  1‏
919 ‎‡a  excessiveneutrophilextracellulartrapformationinancaassociatedvasculitisisindependentofanca‏ ‎‡A  Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.‏ ‎‡9  1‏
919 ‎‡a  gonadalfunctioninmaleandfemalepatientswithclassicgalactosemia‏ ‎‡A  Gonadal function in male and female patients with classic galactosemia.‏ ‎‡9  1‏
919 ‎‡a  allogeneichaematopoieticstemcelltransplantationformitochondrialneurogastrointestinalencephalomyopathy‏ ‎‡A  Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy‏ ‎‡9  1‏
919 ‎‡a  biochemicalabnormalitiesinapatientwiththymidinephosphorylasedeficiencywithfataloutcome‏ ‎‡A  Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.‏ ‎‡9  1‏
919 ‎‡a  adductedthumbsaclinicalcluetogeneticdiagnosis‏ ‎‡A  Adducted thumbs: a clinical clue to genetic diagnosis.‏ ‎‡9  1‏
919 ‎‡a  azathioprineinducedpneumonitisinapatientwithulcerativecolitis‏ ‎‡A  Azathioprine induced pneumonitis in a patient with ulcerative colitis‏ ‎‡9  1‏
919 ‎‡a  accuracyoftheprecisionpointofcareketonetestexaminedbyliquidchromatographytandemmassspectrometrylcmsmsinthesamefingersticksample‏ ‎‡A  Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry (LC-MS/MS) in the same fingerstick sample‏ ‎‡9  1‏
919 ‎‡a  autoantibodydevelopmentundertreatmentwithimmunecheckpointinhibitors‏ ‎‡A  Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors‏ ‎‡9  1‏
919 ‎‡a  accuracyoftheprecisionpointofcareketonetestexaminedbyliquidchromatographytandemmassspectrometry‏ ‎‡A  Accuracy of the Precision® point-of-care ketone test examined by liquid chromatography tandem-mass spectrometry‏ ‎‡9  1‏
919 ‎‡a  inosinetriphosphatepyrophosphohydrolaseactivitymoreaccuratepredictorforribavirininducedanemiainhepatitis100infectedpatientsthanitpagenotype‏ ‎‡A  Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype‏ ‎‡9  1‏
919 ‎‡a  inosinetriphosphatepyrophosphohydrolaseexpressiondecreasedinleukocytesofhivinfectedpatientsusingcombinationantiretroviraltherapy‏ ‎‡A  Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy.‏ ‎‡9  1‏
919 ‎‡a  intrinsicallydistinctroleofneutrophilextracellulartrapformationinantineutrophilcytoplasmicantibodyassociatedvasculitiscomparedtosystemiclupuserythematosus‏ ‎‡A  Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus‏ ‎‡9  1‏
919 ‎‡a  isbrainnatriureticpeptideproductiondecreasedinobesesubjects‏ ‎‡A  Is brain natriuretic peptide production decreased in obese subjects?‏ ‎‡9  1‏
919 ‎‡a  keepingebolaoutofthelabapracticalsolutiononhowtoanalyzeebolaassociatedbloodanomalies‏ ‎‡A  Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomalies‏ ‎‡9  1‏
919 ‎‡a  ldlreceptorknockoutmiceareaphysiologicalmodelparticularlyvulnerabletostudytheonsetofinflammationinnonalcoholicfattyliverdisease‏ ‎‡A  LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease‏ ‎‡9  1‏
919 ‎‡a  metaboliceventsinhivinfectedpatientsusingabacavirareassociatedwitherythrocyteinosinetriphosphataseactivity‏ ‎‡A  Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity‏ ‎‡9  1‏
919 ‎‡a  mutationofthecogcomplexsubunitgenecog7causesalethalcongenitaldisorder‏ ‎‡A  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder‏ ‎‡9  1‏
919 ‎‡a  neutrophilderivedmyeloperoxidaseaggravatesnonalcoholicsteatohepatitisinlowdensitylipoproteinreceptordeficientmice‏ ‎‡A  Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice‏ ‎‡9  1‏
919 ‎‡a  newmutationsin2dutchpatientswithearlyinfantilegalactosialidosis‏ ‎‡A  New mutations in two Dutch patients with early infantile galactosialidosis‏ ‎‡9  1‏
919 ‎‡a  abnormalitiessuggestiveoflatenttuberculosisinfectiononchestradiographyhowspecificarethey‏ ‎‡A  Abnormalities suggestive of latent tuberculosis infection on chest radiography; how specific are they?‏ ‎‡9  1‏
919 ‎‡a  persistentmetabolicchangesinhivinfectedpatientsduringthe1yearofcombinationantiretroviraltherapy‏ ‎‡A  Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy‏ ‎‡9  1‏
919 ‎‡a  roleforitpavariantsintheclinicalcourseofpulmonarylangerhanscellhistiocytosis‏ ‎‡A  A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?‏ ‎‡9  1‏
919 ‎‡a  plasmalevelsofdimethylargininesinpretermverylowbirthweightneonatesitsrelationwithperinatalfactorsandshorttermoutcome‏ ‎‡A  Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome.‏ ‎‡9  1‏
919 ‎‡a  prospectiveplacebocontrolledstudyonthehumoralimmuneresponsetoandsafetyoftetanusrevaccinationinmyastheniagravis‏ ‎‡A  A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis‏ ‎‡9  1‏
919 ‎‡a  preeclampsiainautologousandoocytedonationpregnancyisthereadifferentpathophysiology‏ ‎‡A  Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology?‏ ‎‡9  1‏
919 ‎‡a  novelmultiparameterflowcytometricassayforinosinetriphosphataseexpressionanalysisinleukocytes‏ ‎‡A  A novel multiparameter flow cytometric assay for inosine triphosphatase expression analysis in leukocytes‏ ‎‡9  1‏
919 ‎‡a  pregnancyinclassicgalactosemiadespiteundetectableantimullerianhormone‏ ‎‡A  Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone‏ ‎‡9  1‏
919 ‎‡a  comparativestudyofinosinetriphosphataseactivityinfresherythrocytesanddriedbloodspots‏ ‎‡A  A comparative study of inosine triphosphatase activity in fresh erythrocytes and dried blood spots‏ ‎‡9  1‏
919 ‎‡a  prodhrs450046andproline10comtval158metinteractioneffectsonintelligenceandstartleinadultswith22q11deletionsyndrome‏ ‎‡A  PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  PLWABN|9810616647805606‏
996 ‎‡2  NTA|130985945‏
996 ‎‡2  ISNI|0000000055115383‏
996 ‎‡2  NTA|272902705‏
996 ‎‡2  ISNI|0000000393360285‏
996 ‎‡2  ISNI|0000000392732219‏
996 ‎‡2  NTA|101175159‏
996 ‎‡2  NTA|087799235‏
996 ‎‡2  ISNI|000000039661157X‏
996 ‎‡2  NTA|304360007‏
996 ‎‡2  NTA|170758001‏
996 ‎‡2  NTA|071736786‏
996 ‎‡2  ISNI|0000000392248136‏
996 ‎‡2  LC|n 78073212‏
996 ‎‡2  ISNI|0000000045252368‏
996 ‎‡2  NTA|070445729‏
996 ‎‡2  BIBSYS|90285664‏
996 ‎‡2  NUKAT|n 2021146201‏
996 ‎‡2  DNB|1117063607‏
996 ‎‡2  LC|no2023124199‏
996 ‎‡2  NTA|153199326‏
996 ‎‡2  ISNI|0000000395496936‏
996 ‎‡2  SUDOC|251033783‏
996 ‎‡2  NUKAT|n 2012170055‏
996 ‎‡2  ISNI|0000000387542381‏
996 ‎‡2  ISNI|0000000396737762‏
996 ‎‡2  ISNI|0000000391043833‏
996 ‎‡2  NTA|068633327‏
996 ‎‡2  CAOONL|ncf12093984‏
996 ‎‡2  ISNI|0000000396071569‏
996 ‎‡2  NII|DA00322801‏
996 ‎‡2  NTA|073675830‏
996 ‎‡2  DNB|171046056‏
996 ‎‡2  NTA|426528034‏
996 ‎‡2  NTA|41038013X‏
996 ‎‡2  NTA|074069748‏
996 ‎‡2  NTA|314628312‏
996 ‎‡2  NTA|189633719‏
996 ‎‡2  NTA|395443733‏
996 ‎‡2  LC|no2023035238‏
996 ‎‡2  PLWABN|9811555296905606‏
996 ‎‡2  NTA|406496870‏
996 ‎‡2  LC|n 94047781‏
996 ‎‡2  ISNI|0000000388659522‏
996 ‎‡2  NTA|241271819‏
996 ‎‡2  RERO|A009964533‏
996 ‎‡2  ISNI|0000000389574192‏
996 ‎‡2  NTA|087195135‏
996 ‎‡2  ISNI|0000000393943210‏
996 ‎‡2  LC|n 88215932‏
996 ‎‡2  NTA|06967051X‏
996 ‎‡2  NTA|292655037‏
996 ‎‡2  NTA|085464937‏
996 ‎‡2  NKC|jn20020716304‏
996 ‎‡2  ISNI|0000000037143014‏
996 ‎‡2  JPG|500537598‏
996 ‎‡2  NTA|073713619‏
996 ‎‡2  NTA|071389687‏
996 ‎‡2  DNB|132306964‏
996 ‎‡2  LC|n 92113326‏
996 ‎‡2  NTA|071715266‏
996 ‎‡2  ISNI|0000000393571402‏
996 ‎‡2  NTA|43172413X‏
996 ‎‡2  J9U|987007340159505171‏
996 ‎‡2  JPG|500634533‏
996 ‎‡2  ISNI|0000000393312160‏
996 ‎‡2  ISNI|0000000389289025‏
996 ‎‡2  ISNI|0000000358417338‏
996 ‎‡2  RERO|A026788947‏
996 ‎‡2  JPG|500648228‏
996 ‎‡2  NTA|422752983‏
996 ‎‡2  ISNI|0000000443763534‏
996 ‎‡2  SUDOC|033058881‏
996 ‎‡2  ISNI|0000000387768727‏
996 ‎‡2  NTA|068409400‏
996 ‎‡2  NTA|071748970‏
996 ‎‡2  BIBSYS|90815268‏
996 ‎‡2  CAOONL|ncf11268981‏
996 ‎‡2  NTA|400223740‏
996 ‎‡2  NTA|376075457‏
996 ‎‡2  SUDOC|133427013‏
996 ‎‡2  NTA|090849493‏
996 ‎‡2  NUKAT|n 2023048076‏
996 ‎‡2  NTA|353201219‏
996 ‎‡2  NTA|325845778‏
996 ‎‡2  NTA|151613370‏
996 ‎‡2  NTA|41317252X‏
996 ‎‡2  ISNI|0000000113281495‏
996 ‎‡2  ISNI|0000000042863892‏
996 ‎‡2  BIBSYS|90131175‏
996 ‎‡2  NTA|073587834‏
996 ‎‡2  NTA|151617511‏
996 ‎‡2  ISNI|0000000391113571‏
996 ‎‡2  NTA|130671495‏
996 ‎‡2  NTA|067800173‏
996 ‎‡2  NTA|089600169‏
996 ‎‡2  ISNI|000000039694960X‏
996 ‎‡2  SUDOC|256802971‏
996 ‎‡2  ISNI|0000000395853753‏
996 ‎‡2  ISNI|0000000391315456‏
996 ‎‡2  DNB|1157370365‏
996 ‎‡2  NTA|241271657‏
996 ‎‡2  ISNI|0000000394986888‏
996 ‎‡2  ISNI|0000000392462108‏
996 ‎‡2  NTA|18614699X‏
996 ‎‡2  LC|n 82155759‏
996 ‎‡2  ISNI|0000000391335609‏
996 ‎‡2  DNB|118829505‏
996 ‎‡2  LC|nr 92039082‏
996 ‎‡2  SZ|1180081692‏
996 ‎‡2  NTA|402268970‏
996 ‎‡2  NTA|070248451‏
996 ‎‡2  DNB|170494632‏
996 ‎‡2  ISNI|0000000062352694‏
996 ‎‡2  NTA|241271495‏
996 ‎‡2  ISNI|0000000040824005‏
996 ‎‡2  DNB|1180081692‏
996 ‎‡2  NTA|068303661‏
996 ‎‡2  ISNI|0000000391256337‏
996 ‎‡2  NTA|071008268‏
996 ‎‡2  ISNI|0000000388072983‏
996 ‎‡2  ISNI|0000000391129004‏
996 ‎‡2  BIBSYS|3043482‏
996 ‎‡2  NTA|333677161‏
996 ‎‡2  LC|n 2003093096‏
996 ‎‡2  NTA|07319087X‏
996 ‎‡2  NTA|072179732‏
996 ‎‡2  NTA|357483243‏
996 ‎‡2  NTA|069405786‏
996 ‎‡2  ISNI|0000000392340530‏
996 ‎‡2  NSK|000023234‏
996 ‎‡2  J9U|987007455568205171‏
996 ‎‡2  ISNI|0000000389523977‏
996 ‎‡2  NTA|157309401‏
996 ‎‡2  NTA|10123936X‏
996 ‎‡2  LC|n 88217715‏
996 ‎‡2  ISNI|0000000390954432‏
996 ‎‡2  NTA|331197170‏
996 ‎‡2  NTA|146835387‏
996 ‎‡2  ISNI|0000000387310716‏
996 ‎‡2  ISNI|0000000390583467‏
996 ‎‡2  BIBSYS|90146481‏
996 ‎‡2  NTA|073409677‏
996 ‎‡2  LC|n 2008185083‏
996 ‎‡2  NTA|174392524‏
996 ‎‡2  NTA|071940162‏
996 ‎‡2  ISNI|0000000387184107‏
996 ‎‡2  NTA|241271649‏
996 ‎‡2  J9U|987007317386205171‏
996 ‎‡2  SUDOC|25404171X‏
996 ‎‡2  NTA|426527933‏
996 ‎‡2  ISNI|0000000394255073‏
996 ‎‡2  NTA|073679054‏
996 ‎‡2  NTA|071485198‏
996 ‎‡2  BNF|12455573‏
996 ‎‡2  NTA|071864741‏
996 ‎‡2  NTA|129394831‏
996 ‎‡2  NTA|431724083‏
996 ‎‡2  ISNI|0000000392354473‏
996 ‎‡2  ISNI|0000000387268482‏
996 ‎‡2  NTA|096978724‏
996 ‎‡2  NUKAT|n 97018090‏
996 ‎‡2  NTA|215179234‏
996 ‎‡2  ISNI|0000000392386141‏
996 ‎‡2  NTA|330539221‏
996 ‎‡2  LIH|LNB:BK_u__b_;=B0‏
996 ‎‡2  NTA|298985810‏
996 ‎‡2  ISNI|000000039355811X‏
996 ‎‡2  ISNI|0000000388414541‏
996 ‎‡2  ISNI|0000000119482650‏
996 ‎‡2  ISNI|0000000397071093‏
996 ‎‡2  ISNI|0000000113631811‏
996 ‎‡2  NTA|071235264‏
996 ‎‡2  NTA|431724105‏
996 ‎‡2  NTA|070759111‏
996 ‎‡2  RERO|A002962279‏
996 ‎‡2  RERO|A002962278‏
996 ‎‡2  NTA|072052368‏
996 ‎‡2  LC|no2010126672‏
996 ‎‡2  ISNI|0000000388635192‏
996 ‎‡2  ISNI|0000000396139228‏
996 ‎‡2  ISNI|0000000036746876‏
996 ‎‡2  ISNI|0000000387161335‏
996 ‎‡2  ISNI|0000000396394608‏
996 ‎‡2  NTA|421535962‏
996 ‎‡2  BNF|12396370‏
996 ‎‡2  NTA|069867186‏
996 ‎‡2  NTA|172012147‏
996 ‎‡2  NTA|274592363‏
996 ‎‡2  NTA|170843572‏
996 ‎‡2  NTA|33003166X‏
996 ‎‡2  LC|n 90610943‏
996 ‎‡2  NTA|07170535X‏
996 ‎‡2  NTA|069051143‏
996 ‎‡2  NTA|288381378‏
996 ‎‡2  ISNI|0000000388854133‏
996 ‎‡2  NTA|331461617‏
996 ‎‡2  ISNI|0000000082666471‏
996 ‎‡2  NTA|286878739‏
996 ‎‡2  ISNI|0000000368802491‏
996 ‎‡2  DNB|173368077‏
996 ‎‡2  NTA|070348022‏
996 ‎‡2  SUDOC|122578791‏
996 ‎‡2  J9U|987007374317205171‏
996 ‎‡2  SUDOC|230805671‏
996 ‎‡2  LC|n 81024859‏
996 ‎‡2  NTA|250390914‏
996 ‎‡2  NTA|067813070‏
996 ‎‡2  NUKAT|n 2006007838‏
996 ‎‡2  ISNI|0000000387357688‏
996 ‎‡2  ISNI|0000000050010857‏
996 ‎‡2  NTA|431724113‏
996 ‎‡2  CAOONL|ncf10026478‏
996 ‎‡2  NTA|073310565‏
996 ‎‡2  NTA|324111428‏
996 ‎‡2  NTA|069915083‏
996 ‎‡2  NTA|292638337‏
996 ‎‡2  NTA|325856176‏
996 ‎‡2  ISNI|0000000083841745‏
996 ‎‡2  ISNI|0000000396884893‏
996 ‎‡2  ISNI|0000000388688446‏
996 ‎‡2  NTA|068899866‏
996 ‎‡2  NTA|070836515‏
996 ‎‡2  NTA|27717600X‏
996 ‎‡2  ISNI|0000000392483224‏
996 ‎‡2  NTA|331382938‏
996 ‎‡2  DNB|1047965461‏
996 ‎‡2  ISNI|0000000393784838‏
996 ‎‡2  J9U|987007438555405171‏
996 ‎‡2  LC|n 80025863‏
996 ‎‡2  RERO|A000047366‏
996 ‎‡2  NTA|427435900‏
996 ‎‡2  NTA|292500734‏
996 ‎‡2  SUDOC|237249308‏
996 ‎‡2  NTA|075042134‏
996 ‎‡2  ISNI|0000000066301798‏
996 ‎‡2  ISNI|0000000391034929‏
996 ‎‡2  LC|no 97071518‏
996 ‎‡2  NTA|329899589‏
996 ‎‡2  ISNI|0000000391488971‏
996 ‎‡2  NTA|072147970‏
996 ‎‡2  ISNI|0000000021580471‏
996 ‎‡2  JPG|500031967‏
996 ‎‡2  NUKAT|n 95207970‏
996 ‎‡2  ISNI|0000000394310597‏
996 ‎‡2  ISNI|0000000395260931‏
996 ‎‡2  JPG|500658469‏
996 ‎‡2  NTA|421096454‏
996 ‎‡2  NTA|431724121‏
996 ‎‡2  NTA|089502949‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏